
ContraFect Corporation CFRX
ContraFect Corporation PEG | CFRX
PEG Jährlich ContraFect Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.000024 | -0.000099 | -0.000069 | -0.0955 | -0.021 | -0.0695 | -0.0966 | -0.0422 | -0.158 | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.000024 | -0.158 | -0.0536 |
PEG anderer Aktien in der Pharmaeinzelhändler
| Name | PEG | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AC Immune SA
ACIU
|
2.39 | $ 2.23 | 5.69 % | $ 225 M | ||
|
Aldeyra Therapeutics
ALDX
|
1.65 | $ 0.64 | 4.12 % | $ 38.4 M | ||
|
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | ||
|
Precision BioSciences
DTIL
|
-0.00214 | $ 10.62 | 7.6 % | $ 136 M | ||
|
AIM ImmunoTech
AIM
|
-0.000094 | $ 0.16 | 4.41 % | $ 259 K | ||
|
Ascendis Pharma A/S
ASND
|
4.41 | $ 256.91 | 1.37 % | $ 15.6 B | ||
|
ANI Pharmaceuticals
ANIP
|
0.147 | $ 67.32 | -3.3 % | $ 1.35 B | ||
|
Actinium Pharmaceuticals
ATNM
|
0.175 | $ 1.42 | 9.23 % | $ 44.3 M | ||
|
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.29 | 2.38 % | $ 343 M | ||
|
BridgeBio Pharma
BBIO
|
2.48 | $ 74.28 | 0.01 % | $ 14.2 B | ||
|
BioCryst Pharmaceuticals
BCRX
|
-0.00258 | $ 7.69 | 0.72 % | $ 1.61 B | ||
|
Bicycle Therapeutics plc
BCYC
|
-0.167 | $ 3.6 | 3.45 % | $ 249 M | ||
|
Coherus BioSciences
CHRS
|
-0.0207 | $ 0.77 | 2.9 % | $ 90.2 M | ||
|
Arcutis Biotherapeutics
ARQT
|
6.77 | $ 25.59 | -5.24 % | $ 3.26 B | ||
|
Cellectis S.A.
CLLS
|
0.221 | $ 1.09 | 5.83 % | $ 109 M | ||
|
BeyondSpring
BYSI
|
2.09 | $ 0.61 | -3.32 % | $ 25.1 M | ||
|
Alkermes plc
ALKS
|
-0.493 | $ 45.88 | 3.01 % | $ 7.56 B | ||
|
Altimmune
ALT
|
0.647 | $ 2.09 | 6.09 % | $ 184 M | ||
|
Cardiff Oncology
CRDF
|
185 | $ 0.8 | 5.3 % | $ 53.5 M | ||
|
Citius Pharmaceuticals
CTXR
|
-0.000437 | $ 0.55 | -1.2 % | $ 6.09 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
0.0261 | $ 10.35 | 10.52 % | $ 283 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
-141 | $ 58.16 | 1.22 % | $ 7.78 B | ||
|
Incyte Corporation
INCY
|
0.135 | $ 119.79 | 1.51 % | $ 23.4 B | ||
|
Atara Biotherapeutics
ATRA
|
0.00555 | $ 7.81 | -1.88 % | $ 98 M | ||
|
Aurinia Pharmaceuticals
AUPH
|
0.357 | $ 16.32 | 0.68 % | $ 2.19 B | ||
|
BioNTech SE
BNTX
|
0.00586 | $ 87.46 | 1.86 % | $ 21.1 B | ||
|
Collegium Pharmaceutical
COLL
|
0.288 | $ 24.19 | -3.86 % | $ 766 M | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
-0.0104 | $ 3.07 | 7.34 % | $ 40.9 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
-0.041 | $ 1.26 | -0.79 % | $ 57.6 M | ||
|
AnaptysBio
ANAB
|
0.374 | $ 46.46 | 1.92 % | $ 1.35 B | ||
|
Assembly Biosciences
ASMB
|
-0.453 | $ 20.43 | 2.17 % | $ 229 M | ||
|
Adagene
ADAG
|
0.612 | $ 1.99 | -1.73 % | $ 117 M | ||
|
Benitec Biopharma
BNTC
|
-0.0443 | $ 9.51 | 10.07 % | $ 443 M | ||
|
Denali Therapeutics
DNLI
|
0.0634 | $ 20.09 | 1.88 % | $ 3.47 B | ||
|
Amarin Corporation plc
AMRN
|
0.633 | $ 11.55 | -0.2 % | $ 4.79 B | ||
|
Editas Medicine
EDIT
|
-1.63 | $ 2.57 | 0.59 % | $ 228 M | ||
|
Agios Pharmaceuticals
AGIO
|
-0.339 | $ 29.4 | 4.0 % | $ 1.7 B | ||
|
Cue Biopharma
CUE
|
0.0442 | $ 18.93 | 5.11 % | $ 1.79 B | ||
|
Equillium
EQ
|
-2.61 | $ 1.54 | 15.79 % | $ 88.2 M | ||
|
Black Diamond Therapeutics
BDTX
|
-0.000262 | $ 1.73 | 4.22 % | $ 98.4 M | ||
|
Pliant Therapeutics
PLRX
|
0.0197 | $ 0.81 | -0.12 % | $ 49.7 M | ||
|
Abeona Therapeutics
ABEO
|
-0.00404 | $ 4.18 | 6.78 % | $ 221 M | ||
|
Ironwood Pharmaceuticals
IRWD
|
-0.0413 | $ 4.36 | 8.19 % | $ 706 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
-0.0844 | $ 21.22 | -0.09 % | $ 3.57 B | ||
|
PainReform Ltd.
PRFX
|
-0.00083 | $ 0.85 | 11.62 % | $ 551 K | ||
|
Jazz Pharmaceuticals plc
JAZZ
|
0.07 | $ 235.01 | 3.38 % | $ 14.3 B | ||
|
Atossa Therapeutics
ATOS
|
-0.00563 | $ 2.14 | 5.94 % | $ 18.4 M | ||
|
Liquidia Corporation
LQDA
|
0.000305 | $ 44.53 | 0.08 % | $ 3.83 B | ||
|
Cleveland BioLabs, Inc.
CBLI
|
-1.36 | - | -7.31 % | $ 49 M |